STATE STREET CORP - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2016$221,000
-32.8%
934,220
-0.8%
0.00%
Q4 2015$329,000
-79.9%
941,667
+0.0%
0.00%
Q3 2015$1,634,000
-23.1%
941,271
-1.0%
0.00%
Q2 2015$2,124,000
+38.2%
950,644
+20.2%
0.00%
Q1 2015$1,537,000
-26.6%
790,866
-0.1%
0.00%
Q4 2014$2,095,000
-10.1%
791,411
+2.2%
0.00%
Q3 2014$2,330,000
-25.1%
774,506
+1.9%
0.00%
Q2 2014$3,110,000
-7.2%
759,989
-2.3%
0.00%
Q1 2014$3,352,000
-60.5%
778,198
-35.0%
0.00%
-100.0%
Q4 2013$8,486,000
+121.4%
1,197,560
+97.2%
0.00%
Q3 2013$3,833,000
+26.3%
607,275
-0.2%
0.00%
Q2 2013$3,034,000608,3710.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders